None listed
Conditions
Interventions
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Healthy females aged 40 to 59 years-old. 2)Subjects who aware of coldness. 3)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: 1)Subjects who were diagnosed with serious disease (e.g., diabetes, liver disease, kidney disease, digestive disease, heart disease, respiratory disease and/or peripheral vascular disease). 2)Subjects who had a gastrointestinal surgery. 3)Subjects with strange finger conditions at measurement points. 4)Subjects with a disease currently under treatment. 5)Subjects with food allergies. 6)Subjects with anemic. 7)Women who are/might be pregnant or lactating during the current study periods. 8)Subjects who play high intensity sports and/or are on a diet. 9)Subjects who have an extremely irregular eating habit, are shiftworker and/or midnight-shift worker. 10)Subjects who can't stop using functional foods (including Food for Specified Health Uses or Foods with Function Claims) and/or Specified quasi-drugs during the current study periods. 11)Subjects who are under treatment with medications (including OTC and/or prescribed medications). 12)Subjects who have excessive alcohol intake more than approximately 60 g/day of pure alcohol equivalent, habit of drinking not less than 5 days a week, or can't stop drinking from the days before each measurement. 13)Subjects who smoke 21 or more cigarettes a day, or cannot quit smoking during from waking to inspection completed. 14)Subjects who can't stop their manicure or false nail during the current study periods. 15)Subjects who are participating in other studies or planning to participate at the start of the current study. 16)Subjects who are judged as unsuitable for the current study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Capillary blood flow velocity after 8 weeks of intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Capillary image analysis after 8 weeks of intake | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed